FR2408348A1 - (2,4-Di:oxy-6-methyl-pyrimidinyl-5-sulphonamino) di:phenyl-sulphone - used to treat skin rash caused by rheumatoid arthritis - Google Patents

(2,4-Di:oxy-6-methyl-pyrimidinyl-5-sulphonamino) di:phenyl-sulphone - used to treat skin rash caused by rheumatoid arthritis

Info

Publication number
FR2408348A1
FR2408348A1 FR7731896A FR7731896A FR2408348A1 FR 2408348 A1 FR2408348 A1 FR 2408348A1 FR 7731896 A FR7731896 A FR 7731896A FR 7731896 A FR7731896 A FR 7731896A FR 2408348 A1 FR2408348 A1 FR 2408348A1
Authority
FR
France
Prior art keywords
sulphonamino
pyrimidinyl
methyl
rheumatoid arthritis
sulphone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7731896A
Other languages
French (fr)
Other versions
FR2408348B1 (en
Inventor
Nikolai Mikhailovi Goloschapov
Yakov Alexandrovich Sigidin
Elena Sergeevna Tsvetkova
Ida Leibovna Bilich
Vladimir Savich Re Abdwakhimov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MO G MEDITSI
Original Assignee
MO G MEDITSI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MO G MEDITSI filed Critical MO G MEDITSI
Priority to FR7731896A priority Critical patent/FR2408348B1/en
Publication of FR2408348A1 publication Critical patent/FR2408348A1/en
Application granted granted Critical
Publication of FR2408348B1 publication Critical patent/FR2408348B1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The cpd. p.p-(2,4-dioxy-6-methyl-pyrimidinyl-5-sulphonamino)-diphenyl-sulp- hone is mixed with carrier. A tablet contains 0.1-0.2 gram of the cpd. The carrier is e.g. an injection solvent, distilled water or physiological salt soln. Used to cure red spot rash of human skin caused by rheumatoid arthritis.
FR7731896A 1977-10-24 1977-10-24 MEDICAMENT FOR THE TREATMENT OF COLLAGENOSES OF RHUMATOID ETIOLOGY, BASED ON P, P- (2,4-DIOXO-6-METHYL-PYRIMIDINYL-5-SULFONAMIDO) DIPHENYLSULFONE Expired FR2408348B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7731896A FR2408348B1 (en) 1977-10-24 1977-10-24 MEDICAMENT FOR THE TREATMENT OF COLLAGENOSES OF RHUMATOID ETIOLOGY, BASED ON P, P- (2,4-DIOXO-6-METHYL-PYRIMIDINYL-5-SULFONAMIDO) DIPHENYLSULFONE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7731896A FR2408348B1 (en) 1977-10-24 1977-10-24 MEDICAMENT FOR THE TREATMENT OF COLLAGENOSES OF RHUMATOID ETIOLOGY, BASED ON P, P- (2,4-DIOXO-6-METHYL-PYRIMIDINYL-5-SULFONAMIDO) DIPHENYLSULFONE

Publications (2)

Publication Number Publication Date
FR2408348A1 true FR2408348A1 (en) 1979-06-08
FR2408348B1 FR2408348B1 (en) 1980-06-27

Family

ID=9196844

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7731896A Expired FR2408348B1 (en) 1977-10-24 1977-10-24 MEDICAMENT FOR THE TREATMENT OF COLLAGENOSES OF RHUMATOID ETIOLOGY, BASED ON P, P- (2,4-DIOXO-6-METHYL-PYRIMIDINYL-5-SULFONAMIDO) DIPHENYLSULFONE

Country Status (1)

Country Link
FR (1) FR2408348B1 (en)

Also Published As

Publication number Publication date
FR2408348B1 (en) 1980-06-27

Similar Documents

Publication Publication Date Title
NZ185000A (en) Administering clonidine transdermally
FI860285A (en) 6-TIOXANTINDERIVAT.
JPS53145987A (en) Purification of polymer solution produced by microorganism
DE3376524D1 (en) Skin treatment composition
ES8102141A1 (en) 3,7-Disubstituted-3-cephem-4-carboxylic acid compounds
ZA763155B (en) Improvements in or relating to compounds having a physiological action on the nervous system of the human body and compositions containing them
JPS53124627A (en) Skin cosmetics
ZA787399B (en) Medicine with activity as prostaglandin synthetase inhibitor
AU3502778A (en) Skin treatment using dicarboxylic acid
ZA903758B (en) Dehydrocholecalciferol derivatives
DE2862480D1 (en) Use of retinoids as medicines
FR2408348A1 (en) (2,4-Di:oxy-6-methyl-pyrimidinyl-5-sulphonamino) di:phenyl-sulphone - used to treat skin rash caused by rheumatoid arthritis
ES449597A1 (en) 4-Imino-1,3-diazabicyclo-(3.1.0)-hexan-2-one as a cancerostat and immuno-stimulant
ES8304058A1 (en) 3,7,11,15-Tetramethyl- 2,4,6,10,14-hexadecapentaenoic Acid
ES475050A1 (en) Derivatives of 2,6-dipnenyl-3,7- dioxabicyclo-[3,3,0]-octane-4,8-dione
JPS52108991A (en) Purification of lactam
JPS5417109A (en) Production of aqueous solution for administering into vein
ES458413A1 (en) Pharmaceutical composition
SU1607351A1 (en) 3-BENZOIL-1-PHENYL-1N-PYRAZOLO [3,4-b] CHINOXALINE THAT IS ANTILLOUS ANTI-STATUS ACTIVITY
ES464780A1 (en) Reduction of 2,5 - diketogluconic acid
JPS53109730A (en) Compact pace maker
SU1744810A1 (en) Vasoactive agent "dimephosphone" normalizing vegetative nervous system functions
JPS52130512A (en) Pulse transmission system
ES413453A1 (en) Electronic apparatus muscle neuro exerciator. (Machine-translation by Google Translate, not legally binding)
JPS53113081A (en) Purification of urokinase

Legal Events

Date Code Title Description
ST Notification of lapse